<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12(2)</volume><submitter>Li X</submitter><pubmed_abstract>ABSTRACT A prominent aspect of the post-coronavirus disease-2019 (post-COVID-19) era is long-COVID. Therefore, precise patient classification and exploration of the corresponding factors affecting long-COVID are crucial for tailored treatment strategies. Frailty is a common age-related clinical syndrome characterized by deteriorated physiological functions of multiple organ systems, which increases susceptibility to stressors. Herein, we performed an inclusion and exclusion analysis (definite COVID-19 infection diagnosis, clear underlying disease information, ≥60 years old, and repeated sampling of clinical cases) of 10,613 blood samples and identified frailty cases for further investigation. RNA-Seq data were used for differential gene expression and functional and pathway analyses. The r</pubmed_abstract><journal>Emerging microbes &amp; infections</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10469413</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Mast cell activation may contribute to adverse health transitions in COVID-19 patients with frailty</pubmed_title><pmcid>PMC10469413</pmcid><pubmed_authors>Li X</pubmed_authors><pubmed_authors>Bao Z</pubmed_authors><pubmed_authors>Zhang C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Mast cell activation may contribute to adverse health transitions in COVID-19 patients with frailty</name><description>ABSTRACT A prominent aspect of the post-coronavirus disease-2019 (post-COVID-19) era is long-COVID. Therefore, precise patient classification and exploration of the corresponding factors affecting long-COVID are crucial for tailored treatment strategies. Frailty is a common age-related clinical syndrome characterized by deteriorated physiological functions of multiple organ systems, which increases susceptibility to stressors. Herein, we performed an inclusion and exclusion analysis (definite COVID-19 infection diagnosis, clear underlying disease information, ≥60 years old, and repeated sampling of clinical cases) of 10,613 blood samples and identified frailty cases for further investigation. RNA-Seq data were used for differential gene expression and functional and pathway analyses. The r</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Aug</publication><modification>2025-04-19T20:08:24.35Z</modification><creation>2025-04-19T20:08:24.35Z</creation></dates><accession>S-EPMC10469413</accession><cross_references/></HashMap>